Amaranth Oil Increases Total and LDL Cholesterol Levels without Influencing Early Markers of Atherosclerosis in an Overweight and Obese Population: A Randomized Double-Blind Cross-Over Study in Comparison with Rapeseed Oil Supplementation

• Published in: Nutrients Vol. 11; no. 12; p. 3069
• Main Authors: Dus-Zuchowska, Monika, Walkowiak, Jaroslaw, Morawska, Anna, Krzyzanowska-Jankowska, Patrycja, Miskiewicz-Chotnicka, Anna, Przyslawski, Juliusz, Lisowska, Aleksandra
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 16.12.2019; MDPI
• Subjects: Atherosclerosis; Body mass index; Carbohydrates; Cholesterol; Diet; Disease; Double-blind studies; Eating behavior; Endothelium; Expected values; Fatty acids; Gastroenterology; Intervention; Lipids; Low density lipoprotein; Metabolic disorders; Obesity; Overweight; Oxidative stress; Pediatrics; Proteins; R&D; Research & development; Standard deviation; Minneapolis Minnesota; Poland; United States > US; atherosclerosis; amaranth oil; obesity

Background: Atherosclerosis (AT) is a chronic inflammatory process in which oxidative stress is the key event. Amaranth oil (AmO) has potential hypolipidemic and antiatherogenic effects. The aim of the study was to compare the effects of AmO and rapeseed oil (RaO) supplementation on expression of ea...